- Filed
- Apr 29, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 25, 2025 | 86.98M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $119M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $134M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $101.9M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $130.1M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $167.6M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $197.6M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $337.9M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $361.4M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.1B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.12B |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $72.7M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 89.6M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $0 |
| Capex | Q1 2025 · Mar 31, 2024 | $3.4M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $17.3M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $1.03B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $1.03B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.03 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.03 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $37.3M |
| Rd Expense restated | Q1 2025 · Mar 31, 2024 | $9.4M |
| Net Income | Q1 2025 · Mar 31, 2024 | $2.5M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | $5M |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | $53.2M |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $79.1M |